WallStreetZenWallStreetZen

NASDAQ: GRI
Gri Bio Inc Stock Ownership - Who owns Gri Bio?

Insider buying vs selling

Have Gri Bio Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GRI insiders and whales buy or sell their stock.

GRI Shareholders

What type of owners hold Gri Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Joseph E. Payne185.71%861,250$668.33kInsider
Arcturus Therapeutics Holdings Inc181.93%843,750$654.75kInsider
Walter Marc Hertz83.13%385,510$299.16kInsider
Ofir Levi42.45%196,875$152.78kInsider
Albert Agro37.13%172,189$133.62kInsider
Vipin Chaturvedi37.13%172,189$133.62kInsider
Citadel Advisors LLC18.57%86,125$66.83kInstitution
Richard Ammer10.15%47,063$36.52kInsider
Pharma Gmbh Salmon10.15%47,063$36.52kInsider
Renaissance Technologies LLC8.63%40,000$31.04kInstitution

1 of 3

GRI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GRI6.80%86.05%
APVO34.00%66.00%
SLRX2.20%97.80%
SCNI0.03%0.05%
INM13.28%11.17%Net BuyingNet Buying

Gri Bio Stock Ownership FAQ

Who owns Gri Bio?

Gri Bio (NASDAQ: GRI) is owned by 6.80% institutional shareholders, 86.05% Gri Bio insiders, and 7.16% retail investors. Joseph E. Payne is the largest individual Gri Bio shareholder, owning 861,250.00 shares representing 26.94% of the company. Joseph E. Payne's Gri Bio shares are currently valued at $654.55k.

If you're new to stock investing, here's how to buy Gri Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.